VTYX logo

Ventyx Biosciences (VTYX) EBITDA

Annual EBITDA

-$207.99 M
-$100.04 M-92.67%

December 31, 2023


Summary


Performance

VTYX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVTYXprofitabilitymetrics:

Quarterly EBITDA

-$38.24 M
-$2.85 M-8.04%

September 30, 2024


Summary


Performance

VTYX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVTYXprofitabilitymetrics:

TTM EBITDA

-$164.94 M
+$19.44 M+10.54%

September 30, 2024


Summary


Performance

VTYX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVTYXprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

VTYX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-92.7%+7.5%+19.9%
3 y3 years-647.8%+7.5%+19.9%
5 y5 years-4874.7%+7.5%+19.9%

VTYX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-148.8%at low-115.4%+33.7%-140.0%+20.3%
5 y5-year-4874.7%at low-441.6%+33.7%-2236.0%+20.3%
alltimeall time-4874.7%at low-441.6%+33.7%-2236.0%+20.3%

Ventyx Biosciences EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$38.24 M(+8.0%)
-$164.94 M(-10.5%)
Jun 2024
-
-$35.40 M(-14.4%)
-$184.38 M(-10.5%)
Mar 2024
-
-$41.36 M(-17.2%)
-$206.00 M(-0.5%)
Dec 2023
-$207.99 M(+92.7%)
-$49.94 M(-13.4%)
-$207.05 M(+5.9%)
Sep 2023
-
-$57.69 M(+1.2%)
-$195.53 M(+15.6%)
Jun 2023
-
-$57.01 M(+34.4%)
-$169.14 M(+27.7%)
Mar 2023
-
-$42.42 M(+10.4%)
-$132.43 M(+17.5%)
Dec 2022
-$107.96 M
-$38.42 M(+22.8%)
-$112.67 M(+22.5%)
Sep 2022
-
-$31.29 M(+54.2%)
-$92.00 M(+25.2%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$20.30 M(-10.4%)
-$73.47 M(+6.9%)
Mar 2022
-
-$22.66 M(+27.6%)
-$68.73 M(-17.8%)
Dec 2021
-$83.62 M(+200.6%)
-$17.75 M(+39.1%)
-$83.62 M(+1.5%)
Sep 2021
-
-$12.77 M(-17.9%)
-$82.41 M(+7.4%)
Jun 2021
-
-$15.55 M(-58.6%)
-$76.71 M(+25.4%)
Mar 2021
-
-$37.55 M(+126.9%)
-$61.16 M(+159.0%)
Dec 2020
-$27.82 M(+565.3%)
-$16.55 M(+134.4%)
-$23.61 M(+234.4%)
Sep 2020
-
-$7.06 M
-$7.06 M
Dec 2019
-$4.18 M
-
-

FAQ

  • What is Ventyx Biosciences annual EBITDA?
  • What is the all time high annual EBITDA for Ventyx Biosciences?
  • What is Ventyx Biosciences annual EBITDA year-on-year change?
  • What is Ventyx Biosciences quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Ventyx Biosciences?
  • What is Ventyx Biosciences quarterly EBITDA year-on-year change?
  • What is Ventyx Biosciences TTM EBITDA?
  • What is the all time high TTM EBITDA for Ventyx Biosciences?
  • What is Ventyx Biosciences TTM EBITDA year-on-year change?

What is Ventyx Biosciences annual EBITDA?

The current annual EBITDA of VTYX is -$207.99 M

What is the all time high annual EBITDA for Ventyx Biosciences?

Ventyx Biosciences all-time high annual EBITDA is -$4.18 M

What is Ventyx Biosciences annual EBITDA year-on-year change?

Over the past year, VTYX annual EBITDA has changed by -$100.04 M (-92.67%)

What is Ventyx Biosciences quarterly EBITDA?

The current quarterly EBITDA of VTYX is -$38.24 M

What is the all time high quarterly EBITDA for Ventyx Biosciences?

Ventyx Biosciences all-time high quarterly EBITDA is -$7.06 M

What is Ventyx Biosciences quarterly EBITDA year-on-year change?

Over the past year, VTYX quarterly EBITDA has changed by +$3.12 M (+7.54%)

What is Ventyx Biosciences TTM EBITDA?

The current TTM EBITDA of VTYX is -$164.94 M

What is the all time high TTM EBITDA for Ventyx Biosciences?

Ventyx Biosciences all-time high TTM EBITDA is -$7.06 M

What is Ventyx Biosciences TTM EBITDA year-on-year change?

Over the past year, VTYX TTM EBITDA has changed by +$41.05 M (+19.93%)